Life Sciences

Start preparing now for disclosures in Massachusetts

Pharma Compliance Alert, April 8, 2009

Beginning July 1, every pharmaceutical company must annually disclose to the Massachusetts Department of Public Health any payment or economic benefit with a value of at least $50 made in connection with sales or marketing activities.

“You have a year to do this, but you can’t get all of your data two days before the report is due and then say, okay, who’s going to start looking at what this all means,” says Kate Feola, Esq., an associate with McDermott, Will & Emory, LLP, in Washington, D.C. “It’s a good idea to start tracking it in real time and taking a look at what type of data you have, what category of reporting does it fall into, and get a good sense of what that information is that looking like on an overall basis.”

Download our free white paper, Massachusetts Disclosure Regulations: New Challenges for Pharmaceutical, Medical Device Manufacturers, to learn more about the new law and how your company can prepare for it.